Rahul Shukla
Overview
Explore the profile of Rahul Shukla including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
129
Citations
878
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Saha S, Tandon R, Sanku J, Kumari A, Shukla R, Srivastava N
Int J Pharm
. 2025 Mar;
:125463.
PMID: 40081431
Hormone-related cancers, also known as hormone-sensitive or hormone-dependent cancers, rely on hormones such as estrogen, testosterone, and progesterone for growth. These malignancies, including breast, pituitary, thyroid, ovarian, uterine, cervical, and...
2.
Copper-Induced Neurodegenerative Disorders and Therapeutic Potential of Curcumin-Loaded Nanoemulsion
Hake G, Mhaske A, Shukla R, Flora S
Toxics
. 2025 Feb;
13(2).
PMID: 39997923
Copper accumulation in neurons induces oxidative stress, disrupts mitochondrial activity, and accelerates neuronal death, which is central to the pathophysiology of neurodegenerative diseases like Wilson disease. Standard treatments for copper...
3.
Dubey P, Kaur G, Shukla R
Mol Neurobiol
. 2025 Feb;
PMID: 39994160
Heavy metals, omnipresent in the environment, though imperative in trace quantities for human physiology, become a serious health hazard due to their toxicity. Copper, arsenic, lead, iron, and mercury are...
4.
Jadhav K, Jhilta A, Singh R, Negi S, Sharma S, Shukla R, et al.
ACS Infect Dis
. 2025 Feb;
11(3):665-675.
PMID: 39948692
(Mtb) demonstrates a proclivity for infecting extrapulmonary sites, notably the brain. Treating these extrapulmonary tuberculosis (TB) manifestations is challenging due to the difficulty of drug delivery across the blood-brain barrier....
5.
Mhaske A, Shukla R, Flora S
Toxicol Rep
. 2025 Jan;
14():101874.
PMID: 39811818
Copper (Cu) dysregulation, often stemming from ATP7B gene mutations, exacerbates neurological disorders like Huntington's, Alzheimer's, and Parkinson's diseases. Monoisoamyl 2,3-dimercaptosuccinic acid (MiADMSA) shows promise in mitigating Cu induced neurotoxicity by...
6.
Kumar R, Bai S, Shukla R, Naqvi S
Curr Pharm Des
. 2025 Jan;
PMID: 39781738
Scutellarein, a flavone found in the perennial herb Scutellaria baicalensis, has a wide range of pharmacological actions, such as antioxidant, anti-inflammatory, and neuroprotective. Increasing evidence has emphasized the developing significance...
7.
Garg A, Shukla R, Kumar A, Aggarwal C, Mukhopadhyay A, Khanna N
Microorganisms
. 2025 Jan;
12(12.
PMID: 39770732
Dengue virus (DENV) is transmitted by genus mosquitoes and is responsible for dengue fever (DF) and other severe diseases, posing a significant challenge to the global health system. Currently, anti-dengue...
8.
Mamale K, Shukla S, Mahale P, Mhaske A, Kaundal R, Shukla R
Naunyn Schmiedebergs Arch Pharmacol
. 2025 Jan;
PMID: 39754682
Atopic dermatitis (AD) is a chronic skin inflammatory ailment commonly observed in young children and adults. Various therapeutic modalities are already explored for mitigation of AD but for prolong application...
9.
Jadhav K, Jhilta A, Singh R, Sharma S, Negi S, Ahirwar K, et al.
J Control Release
. 2024 Dec;
378:671-686.
PMID: 39689814
Central nervous system tuberculosis (CNS-TB) is the most severe extra-pulmonary manifestation of tuberculosis (TB), facing significant challenges due to the limited penetration of anti-TB drugs (ATDs) across the blood-brain barrier...
10.
Beg S, Ahirwar K, Almalki W, Almujri S, Alhamyani A, Rahman M, et al.
Drug Discov Today
. 2024 Nov;
30(1):104249.
PMID: 39580022
Pharmaceutical product development involves multiple steps; therefore product quality must be assessed to ensure robustness and acceptability. Raw components, production methods, and ambient conditions yield highly variable end products with...